Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0221002 (
primary hyperparathyroidism
)
4,921
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Urate
metabolism was studied in 53 patients with
primary hyperparathyroidism
. They had compared to controls significantly higher serum urate and reduction of the clearance of urate. In 14 of the tested patients with
primary hyperparathyroidism
serum urate was increased above normal limits. Six months after parathyroidectomy serum urate fell significantly from 365.3 +/- 75.7 mumol/l to 265.7 +/- 48.3 mumol/l, in 26 patients where urate measurements were available before as well as after surgery. Serum urate levels in our patients with
primary hyperparathyroidism
did not correlate with clearance of urate. Levels of serum urate cannot be entirely explained by the decrease in renal clearance of urate. Serum urate levels did not correlate with severity of skeletal changes expressed by serum B-ALP and urinary excretion of hydroxyproline. These results suggest that parathormone does not increase the part of the urate pool coming from the nucleic acids of the increased bone metabolism.
...
PMID:Primary hyperparathyroidism and hyperuricaemia are associated but not correlated with indicators of bone turnover. 343 54
We have investigated and treated 176 patients who were suffering from renal calculi. The stones contained calcium in 87% of patients, predominantly urate in 11%, and rarely contained magnesium ammonium phosphate or cystine. Of the patients with calcium stones, hypercalciuria was present in 75% and was identified in 57% by the measurement of the 24-hour urinary calcium excretion, and in a further 18% by a standardization calcium "fast-and-load" test. Nine patients were found to have
primary hyperparathyroidism
and were treated surgically. A further 21% were suspected to have normocalcaemic hyperparathyroidism, and metabolic studies are being developed to clarify this. The treatment of hypercalciuria included a low-calcium diet, and various combinations of a thiazide diuretic, phosphate supplements and sodium cellulose phosphate. Hypercalciuria was controlled in all compliant patients, and only two developed further stones. Hyperuricosuria was rarely the sole metabolic abnormality in patients with calcium stones, though this might reflect the referral pattern of the Unit.
Uric acid
stones were frequently, but not invariably, associated with hyperuricosuria and acid urine, and even large uric acid calculi dissolved with a combined therapy of high fluid intake, allopurinol and an alkalinizing agent. Surgical treatment was rarely required in these patients. A stone in the renal pelvis of one patient was removed percutaneously and did not require ultrasonic fragmentation. Modern methods of investigation and treatment have greatly improved the outlook for patients with recurrent renal calculi.
...
PMID:Investigation and treatment of renal calculi. 404 15
Urate
metabolism was studied in 40 patients with
primary hyperparathyroidism
(HPT), 20 of them had a history of renal stones. Preoperatively they had, compared to controls, a reduction of the clearance of urate and a rise of the serum urate concentrations. These disturbances were normalized postoperatively. HPT patients, in particular those with a history of stones, had a high urinary calcium excretion probably as a result of both increased bone resorption and intestinal calcium uptake. There was a close relationship between the urinary urate and calcium excretions preoperatively but not after surgery. There were no consistent differences with regard to urate metabolism in the stone-forming individuals with HPT as compared to those who had never formed a renal stone and thus it seems unlikely that disturbances of urate handling are of any particular importance for the well-known propensity to form stones in primary HPT.
...
PMID:Urate metabolism in primary hyperparathyroidism. 711 64